Semantic Scholar search for SemaglutideSemanticScholar
Semaglutide
Research-centric overview
Peptide1 protocol
Summary pending admin curation in the CMS.
Community effect votes, structured logs, and side-effect summaries.
Effect profile (overview)
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Research log summary heatmap
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
Pain / discomfort0/5
Sleep / recovery+1/5
Performance / output+1/5
Based on 1 anonymized research log. Scroll down for full context and methodology.
Anonymous side-effect patterns
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
46%reduced appetite
positive / signal35%early satiety
mixed / neutral19%nausea
negative / cautionTirzepatide vs. Semaglutide: clinical decision-making in the GLP-1 landscape.PubMed
Expert opinion on pharmacotherapy · 2025
Sustained weight reduction with once-weekly semaglutide: results from a real-world retrospective cohort study in the United States (SCOPE 24 months).PubMed
Current medical research and opinion · 2025
GLP-1 receptor agonist utilization is associated with a low risk of Anesthesia-related complications prior to total joint arthroplasty.PubMed
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025
External databases
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
Protocols
View all protocolsCommunity notes
No public comments yet. Use the form below to submit research questions or observations for admin review.
Community research logs (detail)
Showing the latest 1 logs out of 1.
Goal: weight / appetite
Context: sedentary / light • 46-55
Duration ~16.0 weeks • ~1.0 doses/week
Δ scores
Pain +0Sleep +1Perf +1
Weekly GLP-1 agonist with gradual uptitration alongside nutrition coaching. Tracking appetite, weight trend, GI side-effects, and energy levels.
How to read these logs
Each entry is a single, anonymized “n=1” summary with relative change sliders from −5 to +5. Higher positive values indicate perceived improvement; negative values indicate perceived worsening.
Context (training level, age band, duration, and dosing frequency) is shown so you can quickly skim for patterns or outliers. Treat this as qualitative signal layered on top of study data, not as a substitute for controlled trials.
Anonymous side-effect reporting (detail)
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Quick tone breakdown of submitted side-effect tags:
PositiveNegativeNeutral / mixed
Top reported tags so far (color reflects tone):
46%reduced appetite
positive / signal35%early satiety
mixed / neutral19%nausea
negative / cautionQuestions & answers
Ask focused, research-style questions; answers can link to studies or protocols.
No questions yet. You can ask something focused about mechanisms, study design, or protocol choices below.